| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |